🔍 Analysis:
Strategic Partnership: NASDAQ:OPCH has entered a multi-year commercial partnership with Palantir to enhance patient outcomes and operational efficiency through data integration.
Cost Reduction: The collaboration aims to reduce costs and improve margins by streamlining operations.
Institutional Interest: Increased interest from institutional firms...
This is just my basic MONTHLY charting.
I have marked what I see as the POSSIBLE bottom (support).
I see overall DOWNTREND with Possible reversal.
I have marked my potential BUY/SELL LEVELS for LONGS/SHORTS/CALLS/PUTS.